Results 101 to 110 of about 68,419 (263)
Experimental DNA-Launched Live-Attenuated Vaccines Against Yellow Fever
Эпидемиология и вакцинопрофилактика, 2019 Background DNA-launched vaccine is “manufactured” in vaccinated individuals and does not require traditional vaccine manufacturing facility and technology. Goals.
P. Pushko +3 more
doaj +1 more source
Vaccines: Propaganda and Practice [PDF]
, 2008 Vaccines are a cost effective, time tested means of reducing morbidity and mortality. As more and more new vaccines are introduced and more diseases come under the purview of ‘vaccination net’, the routine immunization program is sidelined.\ud This is ...
Baliga, Shantharam B, Baliga, Shrikala
core +1 more source
British Journal of Clinical Pharmacology, Volume 92, Issue 2, Page 515-524, February 2026.Aims Spontaneous reporting of adverse drug reactions (ADR) after a product has reached the market is essential for drug safety. This study analysed patient ADR reports and compared them with reports from the Japanese Adverse Drug Event Report (JADER) database to identify differences and trends.
Masami Tsuchiya +5 more
wiley +1 more source
Dengue disease, basic reproduction number and control [PDF]
, 2011 Dengue is one of the major international public health concerns. Although progress is underway, developing a vaccine against the disease is challenging. Thus, the main approach to fight the disease is vector control.
Alan Zinober +9 more
core +4 more sources
Yellow fever vaccine-associated viscerotropic disease in a young patient evolving to death: a case report [PDF]
, 2023 Marcos Antônio Pereira de Lima +5 more
openalex +1 more source
Construction of Reverse Genetics System for Feline Calicivirus FCV‐BJ616 and Proteomic Analysis
MicrobiologyOpen, Volume 15, Issue 1, February 2026.This study successfully isolated the FCV‐BJ616 strain derived from cats and established a reverse genetics system. In vivo experiments showed that rFCV‐BJ616 exhibits wild‐type virulence, leading to high fever, weight loss, and multi‐organ lesions in infected cats. Proteomic analysis indicated that both rFCV‐BJ616 and FCV‐BJ616 share similar regulatory
Chunmei Xu +9 more
wiley +1 more source
Yellow fever cases in Asia: primed for an epidemic
International Journal of Infectious Diseases, 2016 There is currently an emerging outbreak of yellow fever in Angola. Cases in infected travellers have been reported in a number of other African countries, as well as in China, representing the first ever documented cases of yellow fever in Asia. There is
Sean Wasserman +2 more
doaj +1 more source
Global Health Security in an Era of Explosive Pandemic Potential [PDF]
, 2017 Pandemics pose a significant risk to security, economic stability, and development. Annualized expected losses from pandemics are estimated at $60 billion per year. Despite the certainty and magnitude of the threat, the global community has significantly
Ayala, Ana, Gostin, Lawrence O.
core +1 more source
Compliance with yellow fever and measles vaccines in the revaccination program post‐hematopoietic cell transplantation [PDF]
, 2023 Lucia Testa +7 more
openalex +1 more source
Nano Select, Volume 7, Issue 2, February 2026.This review explores nanoparticle (NP)‐based biosensors and nanovaccine platforms for arboviral infections, highlighting their design, performance, and translational potential. By comparing case studies across viruses, it identifies gold‐standard nanomaterials such as gold NPs (AuNPs), zinc oxide NPs (ZnONPs), molybdenum disulfide (MoS2) nanocomposites,
Peyman Halvaeikhanekahdani +3 more
wiley +1 more source